What's going on in today's pre-market session
By Mill Chart
Last update: Jan 10, 2024
Wednesday's pre-market session: top gainers and losers
Gainers
| Ticker | Change | Comment |
|---|---|---|
| CMND | 34.3% | Exciting news for CLEARMIND MEDICINE INC (NASDAQ:CMND) as their shares soared 34.3% to $2.78 during the pre-market session on Wednesday. In the last month the stock lost 37.27%. |
| XCUR | 30.58% | Investors witnessed a remarkable surge in EXICURE INC (NASDAQ:XCUR) during Wednesday's pre-market session, with the stock price rising 30.58% to $0.81. Today's pre-market session builds upon the previous day's success, as NASDAQ:XCUR continues its upward trajectory following a 10.71% gain. |
| TBIO | 21.89% | TELESIS BIO INC (NASDAQ:TBIO) experienced an impressive 21.89% increase in share price, reaching $0.46 during the pre-market session on Wednesday. Shareholders saw the stock price going 59.85% lower in the past 3 months. |
| GLMD | 18.81% | During Wednesday's pre-market session, GALMED PHARMACEUTICALS LTD (NASDAQ:GLMD) experienced a 18.81% increase, with the stock price reaching $0.53. Shareholders saw the stock price going 25.69% higher in the past month. |
| ICCT | 18.46% | ICORECONNECT INC (NASDAQ:ICCT) experienced an impressive 18.46% increase in share price, reaching $1.54 during the pre-market session on Wednesday. In the last month the share price increased with 36.04%. |
| AMRN | 16.38% | AMARIN CORP PLC -ADR's (NASDAQ:AMRN) stock price is advancing with 16.38% to a price of $1.13. The stock is trading 27.87% higher than 3 months ago. |
| LUCY | 12.98% | INNOVATIVE EYEWEAR INC (NASDAQ:LUCY) experienced an impressive 12.98% increase in share price, reaching $0.49 during the pre-market session on Wednesday. In the last 6 months the stock lost 49.57%. |
| BNOX | 12.9% | Exciting news for BIONOMICS LTD-ADR (NASDAQ:BNOX) as their shares soared 12.9% to $1.4 during the pre-market session on Wednesday. In the last 3 months the stock lost 68.04%. |
| ETWO | 11.98% | Pre-market trading on Wednesday showed positive momentum for E2OPEN PARENT HOLDINGS INC (NYSE:ETWO), as the stock price advanced 11.98% to reach $4.3. In the last 3 months the share price increased with 56.73%. |
| ONCY | 11.29% | ONCOLYTICS BIOTECH INC's (NASDAQ:ONCY) shares rose 11.29% to $1.38 during Wednesday's pre-market session. The stock is trading 33.33% lower than 3 months ago. |
For the full premarket gainers list go to our premarket gainers page.
Pre-market losers
| Ticker | Change | Comment |
|---|---|---|
| AEHR | -16.91% | AEHR TEST SYSTEMS's (NASDAQ:AEHR) shares fell 16.91% to $18.57 during Wednesday's pre-market session. In the last 3 months the share price dropped with 42.31%. |
| TENX | -16.35% | TENAX THERAPEUTICS INC's (NASDAQ:TENX) stock price is declining with 16.35% to a price of $13.1. Yesterday's 13.64% gain in NASDAQ:TENX gives way to a 16.35% decrease in today's pre-market session, showcasing market fluctuations. |
| GRTX | -12.04% | During Wednesday's pre-market session, the shares of GALERA THERAPEUTICS INC (NASDAQ:GRTX) declined by 12.04%, reaching $0.19. After running up 41.42% in yesterday's session, NASDAQ:GRTX is pulling back pre-market. |
| MDRX | -9.85% | VERADIGM INC's (NASDAQ:MDRX) shares fell 9.85% to $9.7 during Wednesday's pre-market session. The stock is trading 20.36% lower than 3 months ago. |
| CLEU | -8.37% | The stock price of CHINA LIBERAL EDUCATION HOLD (NASDAQ:CLEU) is experiencing a decline of 8.37%, reaching $0.18 in today's pre-market session on Wednesday. Despite a promising gain of 12.65% yesterday, NASDAQ:CLEU faces downward pressure with a 8.37% decline in today's pre-market session. |
| ACRS | -7.81% | ACLARIS THERAPEUTICS INC's (NASDAQ:ACRS) stock price decreased by 7.81% to $1.18. In the last month the share price increased with 26.73%. |
| ADTH | -7.77% | ADTHEORENT HOLDINGS CO INC's (NASDAQ:ADTH) shares fell 7.77% to $1.9. The stock is trading 53.73% higher than a month ago. |
| DRRX | -7.76% | DURECT CORPORATION's (NASDAQ:DRRX) shares experienced a 7.76% decline, falling to $0.52 during Wednesday's pre-market session. In the last 3 months the share price dropped with 77.79%. |
| BTBD | -7.39% | Despite yesterday's decline, BT BRANDS INC (NASDAQ:BTBD) experienced a further 7.39% decrease in share price during Wednesday's pre-market session, reaching $2.38. Following yesterday's gain of 35.47%, NASDAQ:BTBD experiences a 7.39% decrease in today's pre-market session, indicating a pullback from the previous session's performance. |
| TAOP | -7.2% | TAOPING INC's (NASDAQ:TAOP) stock price recorded a 7.2% decrease, falling to $1.16. In the last 3 months the stock lost 35.23%. |
Our premarket losers page will show you the full list.
AMARIN CORP PLC -ADR
NASDAQ:AMRN (5/9/2024, 6:28:30 PM)
After market: 0.88 0 (0%)0.88
+0.02 (+1.98%)
AMRN News
3 days ago - Amarin Corporation plcAmarin to Present at H.C. Wainwright 2nd Annual BioConnect Investor ConferenceDUBLIN, Ireland and BRIDGEWATER, N.J., May 06, 2024 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ: AMRN) today announced that Patrick Holt, Amarin’s...
8 days ago - InvestorPlaceAMRN Stock Earnings: Amarin Corp Beats EPS, Misses Revenue for Q1 2024AMRN stock results show that Amarin Corp beat analyst estimates for earnings per share but missed on revenue for the first quarter of 2024.
8 days ago - The Motley FoolAmarin Plc (AMRN) Q1 2024 Earnings Call TranscriptAMRN earnings call for the period ending March 31, 2024.
9 days ago - Amarin Corporation plcAmarin Reports First Quarter 2024 Business Update and Financial Results-- New VAZKEPA® Patent Issued by European Patent Office Extends Intellectual Property Protection in Europe Until 2039 -- -- In Europe, ~35% Revenue...
15 days ago - Amarin Corporation plcAmarin Applauds HealthyWomen’s Citizen’s Petition Urging FDA To Take Further Action On Fenofibrate Prescribing in Patients at Risk of Cardiovascular EventCitizen Petition Spotlights Risks for Patients on Drug Proven to Have No Benefit in Improving Cardiovascular Outcomes and Need for Urgent Regulatory Action to Protect Patients
Citizen Petition Spotlights Risks for Patients on Drug Proven to Have No Benefit in Improving Cardiovascular Outcomes and Need for Urgent Regulatory Action...
17 days ago - Amarin Corporation plcAmarin Announces Results of Annual General Meeting of Shareholders- Shareholders Approve Share Repurchase Program of up to $50 Million -
- Shareholders Approve Share Repurchase Program of up to $50 Million -...
24 days ago - Amarin Corporation plcAmarin to Report First Quarter 2024 Financial Results and Host Conference Call on May 1, 2024a month ago - Amarin Corporation plcAmarin Highlights Key Data Providing Mechanistic Insights into Eicosapentaenoic Acid (EPA) at ACC.24Data Further Advance Understanding of VASCEPA®/VAZKEPA® Potential Mechanism of Action
